Skip to main content

Table 1 Patient Information

From: Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection

Patient

Date HIV+

Date Death1

Prior Therapy2

Visit 1

Visit 2

Visit 3

    

Date

VL3

CD4 Count4

Therapy

Date

VL3

CD4 Count4

Therapy

Date

VL3

CD4 Count4

Therapy

#1

Jun. 1 1986

--

AZT

Apr. 7 1993

2.7

264

ddI, AZT

Jan. 19 1994

2.4

210

ddI, AZT

Oct. 26 1994

3.5

190

AZT

#2

Jan. 1 1989

Oct. 16 1994

ddI

Apr. 7 1993

6.4

187

ddI

Jan. 26 1994

5.6

40

D4T

Sept. 14 1994

5.8

18

None

#3*

Nov. 1 1989

--

ddI

Apr. 6 1993

4.3

144

ddI

Jan. 26 1994

5.3

162

AZT

Sept. 13 1994

5.6

77

AZT

#7*

Jun. 1 1987

--

AZT

Apr. 21 1993

4.5

270

ddI

Jan. 26 1994

4.9

234

ddI

Mar. 9 1995

4.5

146

AZT

#8*

Oct. 1 1988

--

AZT

Apr. 21 1993

3.3

475

ddI

Jan. 12 1994

3.5

338

ddI

Nov. 16 1994

4.4

325

ddI

#19*

Jan. 1 1991

--

ddI

Jun. 2 1993

3.9

77

ddI

Jan. 26 1994

5.3

22

AZT

Nov. 14 1994

4.7

42

AZT

#60

Dec. 1 1988

Apr. 3 1998

AZT

Sept. 14 1994

4.5

48

AZT

Jun. 14 1995

4.9

51

AZT

Feb. 28 1996

5.3

21

ddI

#42

Nov. 1 1989

Oct. 21 1993

AZT, ddC

Oct. 6 1993

5.6

9

None

        
  1. 1Patient #42 passed away during the study and only visit 1 samples were available
  2. 2Antiretroviral therapy in the 6 months preceding visit 11
  3. 3VL - log plasma viral load in log10 (copies)/mL
  4. 4CD4+ cell counts in cells/μL
  5. *Patients for which a 2007 PBL sample was analyzed